Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1480-1481, 2005-01, pp. : 16-16
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Clopidogrel vs ticlopidine: tolerability after coronary stenting
Inpharma, Vol. 1, Iss. 1436, 2004-01 ,pp. :
Access to resources
Recommend
Eptifibatide `highly cost-effective' for coronary stenting
Inpharma, Vol. 1, Iss. 1315, 2001-01 ,pp. :
Eptifibatide `highly cost-effective' for coronary stenting
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 340, 2001-01 ,pp. :
Clopidogrel an alternative to ticlopidine in coronary stenting
Inpharma, Vol. 1, Iss. 1223, 2000-01 ,pp. :
Clopidogrel Resistance: Implications for Coronary Stenting
Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. :